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Abstract
Objective: This research study was conducted to determine the correlation between finger stick
glucose and finger stick hemoglobin A1c values in order to draw conclusions about the
redundancy of the two tests in a rural Jamaican traveling clinic setting. Methods: This study was
conducted using de-identified data from an electronic health record used in clinics in St. Mary’s
Parish, Jamaica. A correlational analysis was completed using the glucose and A1c variables to
determine both the direction and strength of the correlation. Results: A positive correlation of
0.654549 was found in analysis. This correlation did not meet the set threshold for test
redundancy of 0.8 which is of importance to clinical staff who must make decisions about
resource distribution in the clinics of interest.
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Introduction/Literature Review
Diabetes mellitus is a condition that affects people worldwide. Diabetes manifests as
hyperglycemia and, if not sufficiently diagnosed and treated, can lead to a host of health
complications and financial burdens for both individuals and health systems. In developing
nations, such as Jamaica, where healthcare may be delivered in low resource, clinic-based
settings, it may be a challenge to provide gold standard diagnostic testing. For this reason, it is
important to determine the best, feasible set of diagnostic testing.
As mentioned, diabetes is a disease whose prevalence is expanding worldwide. Ferguson,
Tulloch-Reid, and Wilks3 narrowed their research to just examine diabetes in the Caribbean. In
their research, Ferguson, et al.3 assessed epidemiological studies on diabetes across the
Caribbean through a review of published literature and health and governmental reports. The
authors cited that, currently, increasing prevalence of diabetes exists in Caribbean nations.
Studies also project even greater prevalence in the coming years, which was the motivation for
this literature review. Authors broke their findings down by nation as a way to assess countryspecific reasons for increasing prevalence. They followed this with a report of implications for
the Caribbean nations, as a whole. Authors of this study concluded that diabetes continues to be a
public health issue in developing Caribbean nations. They commented on the implications this
has on each country’s finances now and in the future.
In a similar study, Dr. Micheal Boyne2 examined factors involved in the increased
prevalence of diabetes in only the English-speaking Caribbean nations. He performed an
extensive literature review including 131 articles. He found that the prevalence of obesity and
type II diabetes is higher in many of these Caribbean countries than in other developing nations.
Boyne’s summarized the findings in his literature review and postulated that this difference is a
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result of genetics, lifestyle, early life factors like birth weight, and other metabolic factors.
Increased rates of type II diabetes put residents of these nations at higher risk of other health
complications, such as cardiovascular issues. He claims that this raises concern, not just for the
health of the nation, but for the economic burdens that could be placed upon these developing
nations that are losing productive members due to chronic illnesses, like diabetes. His
overarching conclusion is these developing nations must come up with public health solutions to
halt the progression of disease prevalence among their citizens.
Opinions differ on both the accuracy and validity of different tests used in the diagnosis
of diabetes. Barrett, Huggman, and Johnson1 sought to test several of these methods. In their
study, they compared four different screening methods for the diagnosis of diabetes in an
adolescent, Jamaican population. This study was born out of concern of increasing obesity and
type II diabetes prevalence in Jamaica and the authors’ belief that screening should begin earlier
for these diseases because of Jamaica’s lack of healthcare resources. This study included 59 high
school students recruited randomly from schools across Jamaica. Each of these students
underwent a finger stick glucose, finger stick cholesterol, and finger stick HbA1c test. The
values of these tests were compared with the values collected from a venous blood draw. Barrett,
et al. found high levels of agreement between finger stick glucose and the venous draw. In terms
of finger stick HbA1c and finger stick cholesterol, researchers found that there was a significant
deviation from the venous draw, however, they concluded that this difference is not enough to
completely exclude the use of these tests. Overall, the authors believed that each of the three
finger stick tests was found to be valid enough to be used as screening tests in this Jamaican
adolescent population, especially in resource-poor areas. The authors did, however, warn that
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finger stick HbA1c and cholesterol tests should be met with caution as they did show statistically
significant deviations from the venous blood standards.
Beyond simply questioning the validity of HbA1c testing, some in the medical
community have questioned whether the use of HbA1c for diagnosis and screening is even
appropriate use of such testing. In his study, Higgins4 reports the positive and negative view on
HbA1c testing as both screening and diagnostic testing through an analysis of previous literature.
He begins his analysis with a report on the traditional uses of HbA1c, which is monitoring and
observation of glycemic control. Higgins first reviews reasons support for HbA1c testing in
diagnosis and screening. The list includes no patient preparation for testing, the more forgiving
nature of HbA1c measurements for biological variability and recent changes in a patient’s
physiological state (i.e. stress, diet, etc.), and that microvascular complications are better
predicted by HbA1c values. He follows this discussion with objections to screening and
diagnostic uses of HbA1c measurements. First, these objections state that glucose and HbA1c
values do not correlate as well in non-diabetics as they do in diabetics. Second, critics claim that
HbA1c testing is more expensive, and thus not always an option for low resource nations.
Finally, Higgins includes the argument that biological variation in HbA1c is too high for
diagnostic purposes. Overall, Higgins concludes that there is much disagreement about the
effectiveness of HbA1c testing for diagnosis and screening. He supports the position that there
may exist a need for more than one test for diagnostic purposes. This could include the use of
both a glucose test and an HbA1c test for diagnosis.
Diabetes mellitus is a worldwide condition that Ferguson, Tulloch-Reid, & Wilks3 project
only increases in prevalence in coming years. It will, thus, be important to find appropriate
diagnostic testing that will work within each healthcare setting to diagnose patients early and
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avoid some of the complications and burdens described by Boyne2. In a developing nation, such
as Jamaica, this setting is sometimes composed of low resource, traveling clinics. It is, thus,
important to determine how much and what kind of testing is necessary for appropriate treatment
of patients, while also remaining feasible in this setting that lacks resources. Finger stick glucose
and finger stick HbA1c testing are two testing measures that have been used in these clinics
previously. Barrett, Huggman, & Johnson1 validated the use of these tests, especially in lowresource settings, but included some reservations about their accuracy. Unwin, et al.5 shared a
similar distrust in HbA1c values because, according to their research, there was too wide of a
margin of error that could lead to undiagnosed diabetics or over-diagnosed pre-diabetics.
Arguments of advocators and objectors to the use of HbA1c were summarized by Higgins4 and
exposed some of the same arguments. Overall, there still remains a gap in knowledge about
appropriate care for this specific Jamaican clinic setting. Continuation of research in this area
could provide healthcare professionals with a better solution for testing their patients.
Hypothesis/Specific Aims/Research Questions
The main research question is whether a correlation exists between random finger stick
glucose measurements and HbA1c measurements taken in patients in a Jamaican clinical setting.
For this research question, I hypothesize that if a patient’s finger stick glucose and HbA1c values
are compared, then there will be a positive correlation that exists. The second research question
takes into consideration the practical implications of this correlation and asks how does this
correlation impact the need for both types of diagnostic testing for hyperglycemia in a Jamaican
clinical setting. For this question, I hypothesize that the correlation will not be above a threshold
of 0.8, such that, it would not be necessary to use both finger stick glucose and HbA1c testing in
the diagnosis of hyperglycemia in this Jamaican clinical setting
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Methods
Context/Protocol/Data Collection
Before examining and analyzing the data, approval was sought for this project from the
Wright State University IRB. The project was determined to be exempt from IRB research
requirements. To answer both of the stated research questions, data was retrieved from a deidentified data set. This data set was originally acquired from OpenEMR, an electronic health
record used in the setting of the rural Jamaican clinics of interest. Specific data points include
age, sex, BMI, glucose readings, and HbA1c readings. The data reflect measurements of finger
stick glucose and finger stick HbA1c values that have been collected and recorded into the
OpenEMR electronic health record during trips made by students and health professionals with
American Caribbean Experience, in coordination with the Ministry of Health. These
measurements were obtained in clinics in St. Mary Parish in Jamaica from July 1, 2016 through
July 31, 2018. The finger stick glucose measurements were acquired with blood glucose meters
and the HbA1c measurements were taken with an HbA1c meter called the A1Cnow+ system. The
data set includes measurements from only those patients with both glucose and HbA1c
measurements taken at the same clinic visit, creating a sample size of data from thirty-four
patients.
Data Analysis
The values of age, sex, and BMI are used to define the dataset and give more information
about the population being tested. To answer the first research question, a quantitative analysis
was employed to determine the correlation between finger stick glucose and HbA1c
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measurements. This analysis took place in excel using the correlational analysis function. The
findings were also used in the analysis of the second research question.
Results
Data from thirty-four patients was analyzed. Twenty-three (67.65%) of the patients were
female and eleven (32.35%) of the patients were male. The mean and median age of the patients
in the data set was 57.1 years and 57.2 years respectively. Body Mass index was available for
twenty-two of the patients, which had a mean value of 29.49, falling into the overweight
category.
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The table above describes the data used in this study. It is important to note that the finger
stick A1c meter identified values extending to 13.0. Measurements above this value were
recorded as >13 by the A1Cnow+ system.

The graph above shows the relationship between finger stick glucose and finger stick
hemoglobin A1c values. The correlation between these two values was found to be positive
0.654549.
Discussion
This study was built around the question of whether or not a positive correlation exists
between finger stick glucose and finger stick hemoglobin A1c tests. I hypothesized that the
correlational analysis would show that a positive correlation exists when these two values were
collected from patients at the same visit. This hypothesis was based upon the idea that high
levels of glucose in the bloodstream have increased ability to glycosylate hemoglobin which is
the value read in the A1c test. Upon analysis of the data, the correlation was found to be a
positive value, which was consistent with expectations.
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The second research question was intended to extend upon the first question and
potentially have practical implications on the testing that the clinics of interest will use moving
forward, namely, whether the strength of correlation between the two variables is so strong as to
render the use of both tests redundant. Correlations represent the relationship between two
variables and can have a value between 0 and 1. The relationship is between two variables is
found to be stronger when the correlation is closer to the value of 1. My hypothesis is that if the
correlation is above the threshold of 0.8, then the tests show strong agreement and it would be
redundant for patients to undergo both tests. The result of the analysis was a correlation of
strength 0.654549. This value did not exceed the predetermined threshold. The conclusion is that
the two variables do not have so strong a relationship to be considered redundant.
The question of redundancy is important in this clinical setting. These clinics are limited
by the amount of resources available. Finger stick A1c testing, thus, presents challenges. First,
finger stick A1c testing is more expensive than traditional finger stick glucose testing. In a
resource limited setting, it is important to allocate resources to testing and materials that most
benefit patients. Hence, the question of redundancy is one that has implications on whether or
not resources should be allocated to running the finger stick A1c tests. Another issue with finger
stick A1c is the challenge of running the test itself. The test has a specified temperature range,
and the clinics of interest are often warmer than the upper limit of the temperature range. This
leads to the challenge of cooling the tests and keeping them in the correct temperature range to
be used. Given the outcome of the study, it would appear that, depending on the amount of
resources able to be spared, finger stick A1c testing is worth some of the challenges that
performing the test may pose.
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These results are meaningful in the context of the specific patient population in which the
data was collected. The calculated correlation was not an exact 1:1 correlation. An exact
correlation is not expected because a finger stick glucose is a point in time measurement of the
glucose whereas the A1c is an average over the previous three months. One challenge for the use
of glucose, is that these clinics come into an area for one day only and the patients that visit stand
in line, sometimes all day, to be seen by staff. This makes glucose testing particularly
challenging in that patients are not guaranteed to be fasting when the measurements are taken.
Glucose measurements may be significantly elevated above fasting levels depending on the
timing and content of their last meal. Challenges may arise in using these measurements in
treatment decisions. Thus, A1c testing is potentially a beneficial tool in this setting as A1c is
thought to provide a better idea of glycemic control in a patient’s recent past.
Previous research has implications on the current study. Dr. Micheal Boyne2 explained
that there is a need for changes in public health to occur in Caribbean nations in order to combat
the increasing prevalence of diabetes. Other researchers have gone on to study some potential
answers to this public health question. Barrett, Huggman, & Johnson1, Higgins4, Unwin, et al.5
have all focused their studies on hemoglobin A1c testing which is the topic of the current study.
Barrett, Huggman, & Johnson1 and Higgins4 both researched and then drew conclusions about
using A1c tests in screening and diagnosis. The researchers supported the conclusion that there
are several drawbacks to using hemoglobin A1c testing, but they concluded that, despite the
issues posed by the testing, it may still be beneficial to continue to use A1c testing in screening
and diagnosis. This supports the results of the current study which found that A1c testing may be
indicated along with glucose testing. Unwin, et al.5, on the other hand, supported the opposite
conclusion. They concluded that A1c testing should be mistrusted due to the wide margin of
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error of the test. They suggested that the testing could lead to over or underdiagnoses of
diabetics. In the clinical setting of interest, this could be harmful. Both clinics and patients have
low access to resources. It is important that patients are only being treated for the medical
conditions that they have and resources are not wasted on medical conditions that are not severe
enough to warrant treatment. Overall, previous research illustrates a need new public health
measures in Caribbean nations like Jamaica, although there are ambiguous conclusions about the
utility of hemoglobin A1c testing.
Conclusion
Limitations of this study exist. The first limitation of the study is the relatively small
patient population. De-identified data from patients was only included in the study if they had
both finger stick glucose and finger stick A1c done during the same clinic visit. Additionally, the
data was only collected from patients who visited the clinics in the past two years. This
timeframe has to do with the initiation of finger stick A1c testing in the clinics. While a larger
sample size would likely not impact the positive nature of the correlation, the strength of the
correlation between the two variables may be influenced.
Generalizability is also another potential limitation. This study was performed using data
from traveling rural clinics in St. Mary Parish, Jamaica. This clinical environment has unique
challenges that may differ from many other clinical environments. In the clinics, there is a lack
of resources. On such is that the rural clinical settings do not provide the opportunity to run
laboratory blood tests. This means that A1c measurements must be done by fingerstick. In
previous research done by Barrett, Huggman, and Johnson1, it was shown that there is a
significant deviation of fingerstick A1c from venous blood values. However, the authors
concluded that there was still utility in using the test results. Further, the A1Cnow+ system could
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be a limitation of the study. This system reports fingerstick A1c measurements. The
measurements are reported out in value up to 13.0. Any values of A1c read by the system as
being above 13.0 are reported by the system as >13.0. This is a potential limitation because it
alters the correlational analysis
In the future, this research could be furthered in a couple of ways. First, the research could be
extended to adolescents. Current literature, such as, articles written by Barrett, Huggman, and
Johnson1 and Dr. Michael Boyne2 explain the rising incidence and prevalence of type 2 diabetes
mellitus in Caribbean nations like Jamaica. Barrett’s article specifically talks about screening of
adolescents and how this may impact the course of diabetes by diagnosing early or catching
those at risk before diagnosis. Expanding the current study to include adolescents from the
clinics of interest can give a better idea of what testing, if any, is beneficial for screening
younger patients in this patient population. If a strong indication for this testing exists,
adolescents at risk of diabetes as evidenced by high finger stick glucose and finger stick A1c, can
have interventions early.
This study can be furthered to discuss medical management of patient’s diabetes. Before
finger stick A1c testing was implemented in the clinics, patients were only subjected to finger
stick glucose. There are drawbacks to using only finger stick glucose for deciding upon medical
management of diabetes, including, especially in this setting, the variability of values given type
and timing of last meal. Hemoglobin A1c could be beneficial in this setting because it may give a
better idea of what the patient’s glycemic control is over a longer period of time. Research could
continue to determine if there is a difference between the medical decision physicians make
about pharmaceutical treatment based upon finger stick glucose alone versus both glucose and
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A1c values. The outcomes of the study would have great impact on further diminishing
redundant testing in clinic.
In conclusion, a positive correlation was found between finger stick glucose and finger
stick hemoglobin A1c in this patient population, confirming that both glucose and A1c values
rise together. When the strength of correlation was analyzed, it was found to not meet the set
threshold of 0.8. This lead to the conclusion that the relationship between the two tests is so
strong that the tests to be considered redundant in screening and diagnosing diabetes. This is an
important consideration for the clinics of interest which have limited resources and need to
decide how to distribute them. The results of the study suggest that it may be beneficial for
resources to be allocated for both finger stick glucose and finger stick A1c testing to benefit
patients seen in these rural Jamaican clinics.
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